Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear
CDC director: Data show the fit of masks impacts their effectiveness
House COVID-19 package to include funding for vaccines, testing and boosting Medicaid payments
BioNTech gets rolling with mRNA production at former Novartis site in Marburg
Here's a look at just how much COVID-19 hospitalizations cost
COVID-19 tracker: WHO recommends AstraZeneca's shot for all adults as company plots Euro manufacturing boost
UPDATED Coronavirus tracker: NASA taps Fitbit to monitor astronauts, employees for COVID-19 symptoms

Featured Story

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

By Eric Sagonowsky

Two weeks after Eli Lilly unveiled data showing its COVID-19 combo of bamlanivimab and etesevimab slashed the risk of death and hospitalization for high-risk patients, the antibody cocktail has won its emergency FDA authorization. The nod squares Lilly up to Regeneron, which till now had the only authorized dual-antibody coronavirus cocktail.

CDC director: Data show the fit of masks impacts their effectiveness

By Tina Reed

Speaking at a White House briefing on the COVID-19 pandemic on Wednesday, CDC Director Rochelle Walensky, M.D., urged Americans not to grow complacent as she pointed to new data about the effectiveness of masks.

House COVID-19 package to include funding for vaccines, testing and boosting Medicaid payments

By Robert King

The House Energy & Commerce Committee unveiled its part of a $1.9 trillion COVID-19 relief package that includes funding for vaccines and testing as well as enticing states to expand Medicaid.

BioNTech gets rolling with mRNA production at former Novartis site in Marburg

By Eric Sagonowsky

BioNTech, under pressure with its COVID-19 vaccine partner Pfizer to manufacture as many doses as possible this year, has started production at a site in Germany it acquired from Novartis. The site will be able to turn out up to 750 million doses annually once it's fully online.

Here's a look at just how much COVID-19 hospitalizations cost

By Paige Minemyer

New data from the Blue Cross and Blue Shield Association take a look at just how much COVID-19 cases are costing insurers.

COVID-19 tracker: WHO recommends AstraZeneca's shot for all adults as company plots Euro manufacturing boost

By Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale

WHO recommended AstraZeneca's vaccine for all adults ages 18 and up. AstraZeneca aims to accelerate finished vaccine output in Europe, and Korea approved AZ's shot for emergency use. Plus, some patients developed a rare blood disorder after getting Pfizer or Moderna's shots, though a direct link hasn't been confirmed.

UPDATED Coronavirus tracker: NASA taps Fitbit to monitor astronauts, employees for COVID-19 symptoms

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

COVID-19 Tracker